Actively Recruiting
Evaluating Sentinel Lymph Node Biopsy versus Standard Surgery in High-Risk Cutaneous Squamous Cell Carcinoma
Led by Germans Trias i Pujol Hospital · Updated on 2026-08-19
142
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying high-risk cutaneous squamous cell carcinoma HRcSCC, a type of skin cancer that can spread to nearby lymph nodes, making treatment harder and reducing chances of recovery. This study aims to determine if detecting cancer spread at an early stage by examining the sentinel lymph node can improve health outcomes and survival for patients with HRcSCC who show no signs of cancer spread at diagnosis. Participants will be randomly assigned to one of two groups. One group will have surgery to remove the skin cancer along with a sentinel lymph node biopsy to check for early spread if cancer cells are found, additional treatments like lymph node removal may follow. The other group will receive standard care, which involves surgery to remove the skin cancer and regular follow-up visits, with further treatment only if cancer spread is later detected. Both groups will have regular follow-ups for five years including medical exams and imaging tests. During the study, participants will undergo medical examinations and imaging to monitor for cancer recurrence or spread. Researchers will measure overall survival, disease-free time, local recurrence, and presence of regional or distant metastases over a five-year period. The study seeks to identify whether early sentinel lymph node examination improves detection and outcomes, and to find which patients may benefit most from this approach.
CONDITIONS
Brief Title
Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here